Bullish option flow detected in ImmunityBio (IBRX) with 29,532 calls trading, 1.2x expected, and implied vol increasing over 4 points to 105.42%. May-26 7.5 calls and 4/24 weekly 8.5 calls are the most active options, with total volume in those strikes near 11,400 contracts. The Put/Call Ratio is 0.15. Earnings are expected on May 11th.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBRX:
- ImmunityBio Faces Lawsuit Over Anktiva Promotion After FDA Warning Letter
- ImmunityBio reports preliminary Q1 net product revenue $44.2M
- ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
- ImmunityBio addresses FDA correspondence, reaffirms commitment to ad compliance
- ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up